Physician profile
Sonya Lee
NPI 1013944073
$3,127.51
in general payments reported to CMS, 2019-2025
24 companies · $310 in 2025
The $310 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $443 · 2021: $818 · 2022: $310 · 2023: $411 · 2024: $368 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,088.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,385.54 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $306.00 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $251.36 | 2019-2021 | |
| Astellas Pharma US INC | $188.89 | 2023-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $151.69 | 2021-2024 | |
| Evofem Biosciences, INC. | $92.59 | 2020-2024 | |
| Coopersurgical, INC. | $87.57 | 2019-2025 | Endosee, Paragard T 380a |
| Hologic Sales and Service, LLC | $85.25 | 2019-2024 | Aptima |
| Baxter Healthcare | $78.84 | 2020-2024 | Perclot |
| Bayer Healthcare Pharmaceuticals INC. | $62.97 | 2020-2023 | |
| Allergan, INC. | $55.92 | 2019-2020 | |
| Millicent US INC | $53.06 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $52.09 | 2021-2022 | |
| Lupin INC. | $39.71 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $38.20 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $38.11 | 2019 | |
| Meditrina | $26.56 | 2025 | |
| Avion Pharmaceuticals | $25.90 | 2019-2021 | |
| Myovant Sciences INC. | $25.18 | 2021 | |
| Lilly USA, LLC | $19.63 | 2025 | Zepbound |
| Shield Therapeutics INC | $18.35 | 2022 | |
| Novo Nordisk INC | $17.07 | 2023 | |
| Merck Sharp & Dohme LLC | $13.95 | 2019 | |
| Dysis Medical, INC. | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.